Latest Breaking News On - Jim rodberg - Page 1 : comparemela.com

Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer

MENLO PARK, Calif., April 03, 2023 Sight Sciences, Inc. , an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives,. | April 3, 2023

United statesAlison ali bauerleinPhilip taylorPaul badawiSanta barbaraJim rodbergGelesis holdings incPear therapeutics incCompany tearcareSight sciencesExchange commissionSecurities exchangeUniversity of californiaGilmartin groupSight sciences incKoya medical inc

Sight Sciences Appoints Ali Bauerlein as Chief Financial

MENLO PARK, Calif., April 03, 2023 (GLOBE NEWSWIRE) Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology.

United statesAlison ali bauerleinJim rodbergPaul badawiPhilip taylorSanta barbaraSight sciences incPear therapeutics incGelesis holdings incGilmartin groupKoya medical incSight sciencesSecurities exchangeInogen incUniversity of californiaExchange commission

Sight Sciences, Inc (NASDAQ:SGHT) Q4 2022 Earnings Call Transcript

Operator: Hello, and welcome to Sight Sciences Fourth Quarter 2022 Earnings Results. At this time, all participants are in listen-only mode.

United statesThomas stephanJim rodbergTom stephanTom huangPhilip taylorRosshelen shutterstockPaul badawiSight science coAmerican glaucoma societyAmerican academy of ophthalmology irisExchange commissionVerana healthSight sciences fourth quarterSight sciencesInternational ophthalmology

Sight Sciences (SGHT) Reports Prelim Q4 Revenue of $20 4M-$20 6M

Sight Sciences (SGHT) Reports Prelim Q4 Revenue of $20 4M-$20 6M
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesStaffan encrantzUpdatemack hicksJim rodbergTransitionjesse selnickPaul badawiPhilip taylorgilmartin groupExchange commissionCompany tearcareSecurities exchangeFinancial disclosure advisorythe companySight sciences board of directorsAbbott laboratoriesSight sciencesSight sciencessight sciencesSight sciences inc